Table 5.
Factors | Unadjusted analysis | Adjusted analysis | ||
---|---|---|---|---|
HR (95% CI) | p values | HR (95% CI) | p values | |
Gender | ||||
Female | 0.724 (0.465–1.126) | 0.151 | 0.741 (0.466–1.176) | 0.203 |
Male | ||||
Age, years | ||||
< 65 | 1.321 (0.753–2.318) | 0.332 | 1.278 (0.712–2.294) | 0.411 |
≥ 65 | ||||
BMI, kg/m2 | ||||
< 18.5 | Ref | Ref | ||
18.5–23.9 | 1.717 (0.517–5.702) | 0.378 | 1.860 (0.526–6.582) | 0.336 |
≥ 24 | 1.344 (0.378–0.226) | 0.226 | 1.046 (0.628–1.741) | 0.863 |
Lesion segment | ||||
Chest and back | 0.826 (0.497–1.372) | 0.461 | 1.131 (0.658–1.946) | 0.655 |
Waist and abdomen | ||||
Lesion side | ||||
Left | 1.137 (0.727–1.778) | 0.574 | 1.139 (0.717–1.810) | 0.580 |
Right | ||||
Course of disease, months | ||||
1–3 | 2.389 (1.484–3.845) | < 0.001 | 2.086 (1.277–3.409) | 0.003 |
> 3 | ||||
Type of RF electrode | ||||
Monopole | 0.200 (0.063–0.633) | 0.006 | 0.258 (0.080–0.831) | 0.023 |
Bipolar | ||||
Complications | ||||
No | 2.010 (1.198–3.372) | 0.008 | 1.740 (1.015–2.983) | 0.044 |
Yes | ||||
Treatment history | ||||
Medication | 0.710 (0.365–1.382) | 0.313 | 0.836 (0.422–1.658) | 0.609 |
Neuromodulation | ||||
Pain grade | ||||
Moderate | 3.188 (2.013–5.050) | < 0.001 | 2.724 (1.654–4.485) | < 0.001 |
Severe |
BMI Body mass index